D.for ID/AST cards/reagents for option 2 covering 1 OCT 2019 to 30 SEP 2020
Ended Awarded Last action
- Contract number
- W81K0219F0117
- Awardee
-
Biomerieux Inc. UEI HCNVCMEG9NL6
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $80,185
Award facts
- Opportunity
-
- W81K0217T0313 Solicitation number
- Microbial identification and antibiotic susceptibility testing cards for Vitek 2 analyzer Award Notice · Posted Sep 27, 2017
- Microbial identification (ID) and antibiotic susceptibility testing (AST) cards for Vitek 2 analyzer Award Notice · Posted Jun 20, 2017
- Microbial identification (ID) and antibiotic susceptibility testing (AST) cards for Vitek 2 analyzer Award Notice · Posted Jun 7, 2017
- Contract value 100% obligated
- $80,185.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27712, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$125,184 | |
| Supplemental Agreement for work within scope | -$10 | |
| Funding Only Action | $205,380 | |
| Original award | $0 |
About this award
This federal contract award W81K0217D0012|W81K0219F0117 was issued by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global in vitro diagnostics company, for the provision of ID/AST cards and reagents. The $80,185.02 firm-fixed-price delivery order is for a period of one year from October 1, 2019 to September 30, 2020. The contract does not have a set-aside designation.
Biomerieux Inc., through its Biomerieux, Inc. division, is a leading manufacturer of specialized diagnostic equipment, reagents, and supplies, including its proprietary VITEK, BioFire, and VIDAS systems. The company has received numerous federal contracts and delivery orders from agencies such as the Department of Veterans Affairs, Department of Defense, and Indian Health Service to support their clinical laboratory operations and infectious disease testing requirements. This award is likely part of Biomerieux's existing Indefinite Delivery Vehicle (IDV) contracts, such as its $194 million Federal Supply Schedule contract for in vitro diagnostics, which enables efficient procurement of the company's products across the government.
Quick answers
Who was awarded contract W81K0219F0117?
W81K0219F0117 was awarded to Biomerieux Inc. by Medical Command (Department of the Army) on October 1, 2019.
How much is contract W81K0219F0117 worth?
The government has obligated $80,185 on W81K0219F0117.
Is contract W81K0219F0117 an order under another contract?
Yes. W81K0219F0117 is a delivery order under W81K0217D0012, an indefinite delivery contract.
Was contract W81K0219F0117 competed?
The extent of competition for W81K0219F0117 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award